Advanced Practice Midwife in Nellis Afb, NV Accepting Medicare

5 Advanced Practice Midwife nurses found. Showing 1 - 5

Ms. Sierra Lytera Nicole Payton, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 4700 Las Vegas Blvd N, Nellis Afb, NV 89191 Phone: 702-653-2273

Shameka Lashay Williams, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 4700 Las Vegas Blvd N Bldg 1300, Nellis Afb, NV 89191 Phone: 702-653-2300    Fax: 702-653-2109

Dr. Michele N Mcmahon, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 4700 Las Vegas Blvd N, Nellis Afb, NV 89191 Phone: 702-653-2257

Miss Lorie Bounds, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 4700 Las Vegas Blvd N, Nellis Afb, NV 89191 Phone: 702-653-2300

Lynn Marie Harvey, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 4700 Las Vegas Blvd N, 99 Msgs/sgcg, Nellis Afb, NV 89191 Phone: 702-653-2300    Fax: 702-653-2109

News Archive

U.K. Human Fertilisation and Embryology Authority approves compensation for eggs donated for research

The United Kingdom's Human Fertilisation and Embryology Authority on Wednesday approved a policy that will allow women who donate eggs for human embryonic stem cell research to receive up to $500 for each cycle to cover costs associated with travel and lost wages, the AP/Washington Post reports

Epeius Biotechnologies' tumor-targeted vaccine technology for cancer immunotherapy receives patent protection

Epeius Biotechnologies Corporation, an emerging leader in the field of targeted genetic medicine, received a notice of allowance from the USPTO for a crucial patent covering its leading tumor-targeted vaccine technology for cancer immunotherapy. The issuance of this valuable patent protection for tumor targeted immunotherapy follows on the heels of two international patents covering targeted gene medicine in the U.S. and Europe, respectively, and places Epeius Biotech at the forefront of these emerging fields of clinical medicine with best-of-breed solutions and incontrovertible proofs-of-principle in the clinic.

Mylan enters settlement agreement with Forest Laboratories, Merz Pharmaceuticals for Namenda

Mylan Inc. today announced that it has entered into settlement and license agreements with Forest Laboratories and Merz Pharmaceuticals related to Namenda® Tablets, 5 mg and 10 mg, known generically as Memantine Hydrochloride (HCl) Tablets.

FDA clears Hotspur's new balloon dilatation and embolectomy catheters

Hotspur Technologies, Inc. announced today that it has received FDA clearance for the first three commercial products in its portfolio. These products are based on Hotspur's unique and groundbreaking technology that makes dialysis access interventional and peripheral vascular procedures that open blood vessels less expensive, more efficient, and less invasive for patients.

Read more Medical News

› Verified 5 days ago